Treatment for Non-Melanoma Skin Cancer in Dallas
Superficial Radiation Therapy with Sensus Healthcare SRT-100™
A cancer diagnosis can be scary, even for patients dealing with non-melanoma skin cancer. Dallas dermatologist Dr. Ellen Turner understands that, which is why she offers patient education along with highly effective treatments designed to maximize the health and look of skin impacted by basal cell and squamous cell carcinomas.
The Sensus Healthcare SRT-100™ is a nonsurgical treatment that uses superficial radiation therapy to destroy non-melanoma skin cancer cells without the need for incisions. Patients can avoid the duration and side effects of surgery while still enjoying the benefits of a successful treatment. The lack of surgical scarring is a considerable benefit for patients dealing with cancer in a cosmetically sensitive area, such as the ear, nose, or eyelid.
What is the SRT-100™?
From Sensus Healthcare, the SRT-100™ is a device that uses low-dose radiation to target and destroy non-melanoma skin cancer cells, as well as keloid-forming tumor cells. It works by delivering superficial radiation therapy just five millimeters into the skin, impacting the cancer cells while leaving healthy tissue intact.
SRT-100™ Treatment Details
Before moving forward with any treatment, patients will have a consultation with their dermatologist, who will examine their lesion, confirm non-melanoma skin cancer if necessary, and determine whether superficial radiation therapy is the best option. This may involve a skin biopsy or taking a sample to be tested. Not all patients are candidates for the procedure, and its appropriateness depends on a variety of factors, including the size, type, location, and stage of cancer.
For those who are a good candidate, a single treatment for non-melanoma skin cancer takes only minutes to perform once the preparations have been made. The device works quickly and with precision, delivering carefully calibrated radiation only where it is needed most. Patients typically require eight to 15 treatments in order to achieve their ideal results.
There is no need for the sort of aftercare and recovery time associated with surgical tactics. Superficial radiation therapy for non-melanoma skin cancer also reduces the risk of infection and scarring typical of treatments that involve incisions.
What Is Non-Melanoma Skin Cancer?
There are three main types of skin cancer. From most common to least common, they are basal cell carcinoma, squamous cell carcinoma, and melanoma.
Basal cell carcinoma forms in the basal cells, which make up the base layer of the epidermis. It is a slow-moving cancer that rarely spreads beyond where it first forms, though it can grow both wide and deep if left unchecked, damaging the skin and even bone below.
Squamous cells form the bulk of the outermost layer of skin. Cancer that forms in these cells is less common, but is more likely to grow and spread if left untreated.
Even less common but more deadly is melanoma, which forms in the pigment-producing cells known as melanocytes. If caught early, this cancer has a high cure rate, but if left untreated for too long, it can metastasize—spread to other areas of the body. This cancer is typically treated by more intense radiation therapy, chemotherapy, or other strategies.
Because of the generally localized nature and slower spread of non-melanoma skin cancers, they are suited for superficial radiation therapy from the SRT-100™. Dr. Ellen Turner and her team can explain more to patients interested in this treatment.